COMMUNIQUÉS West-GlobeNewswire

HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences
09/05/2025
DRAPER, Utah, May 09, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its [...]
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
09/05/2025
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label extension NEW YORK, [...]
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
09/05/2025
First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compared to Current [...]
Just in Time for Mother's Day: FamilyWell’s Maternal Mental Health Program Now Accessible in Four States
09/05/2025
BOSTON, May 09, 2025 (GLOBE NEWSWIRE) -- Available in Four States — Having already established a strong presence in Massachusetts and New Hampshire, FamilyWell Health is now extending its reach to Texas and Connecticut [...]
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
09/05/2025
Exclusive agreement includes up to $125 million in upfront and milestone payments to LENZ together with double-digit royalties on future net sales SAN DIEGO and TAIPEI, Taiwan, May 09, 2025 (GLOBE NEWSWIRE) -- LENZ [...]
Celularity Announces Full Year 2024 Operating and Financial Results
09/05/2025
Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year. FLORHAM PARK, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. ( [...]
Vystar Develops Revolutionary Leap in Air Purification Utilizing its Patented Hughes Reactor
09/05/2025
Boston, MA, May 09, 2025 (GLOBE NEWSWIRE) -- Vystar ® Corporation (OTCQB: VYST) Vystar has completed what it believes to be a revolutionary, next-generation RXAIR prototype using the new Fluid Energy Conversion - Hughes [...]
SRx Health Solutions Announces Intention to Create Subsidiary for Crypto-Based Borrowing
09/05/2025
Proposed subsidiary will borrow Solana, Bitcoin and other cryptocurrencies to leverage its existing assets TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), [...]
Nelipak® Healthcare Packaging to Expand Operations in Costa Rica
09/05/2025
New production site will enhance Nelipak’s capacity and capabilities to support the Costa Rica life sciences hub CRANSTON, R.I., May 09, 2025 (GLOBE NEWSWIRE) -- Nelipak ® Corporation (“Nelipak ® ”), a leading global [...]
Safest Steroids - Best Legal Steroids For Muscle Growth (Bulking & Cutting) By CrazyBulk USA
09/05/2025
New York City, NY, May 09, 2025 (GLOBE NEWSWIRE) -- In bodybuilding, wanting to get significant growth of strength and muscle in a really short period of time will make the user resort to anabolic steroids. The ensuing [...]
4 Best Fat Burners for Women Over the Counter and Online 2025 - Top Fat Burning Supplements and Pills for Female Weight Loss - Wolfson Brands
09/05/2025
Glasgow, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight can be tough, especially when stubborn fat just doesn’t seem to budge. But here’s the good news: 2025 brings a new wave of powerful, over-the-counter fat burners [...]
PhenQ Review 2025: Does It Really Work For Weight Loss? Ingredients, Side Effects & Real Results
09/05/2025
Discover everything you need to know about PhenQ in our detailed 2025 review. We break down the key ingredients, potential side effects, and the real results users have experienced. Is it the ultimate weight loss [...]
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
09/05/2025
- Essai de phase II portant sur le pétosemtamab en association avec le pembrolizumab en 1re ligne de traitement dans le CETC r/m exprimant PD-L1 en cours et données cliniques mises à jour lors de la réunion annuelle [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
09/05/2025
COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
09/05/2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
09/05/2025
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4% Total Rare Disease quarterly net revenues of $69.0 million, which includes: Purified Cortrophin® Gel net revenues of [...]
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
09/05/2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
09/05/2025
FRIENDSWOOD, Texas, May 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the first [...]
Vireo Growth Inc. Announces First Quarter 2025 Results
09/05/2025
– Q1 revenue of $24.5 million increased 1.9% year-over-year, in line with expectations for Vireo’s established markets – – Merger Transactions expected to begin closing in Q2 and further strengthen profitability profile [...]

Pages